Welcome to our dedicated page for ICON plc SEC filings (Ticker: ICLR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ICON plc filings document current-report disclosures for a foreign private issuer in the clinical research organization sector. Form 6-K reports furnish press releases and exhibits on operating results, financial guidance, earnings-call scheduling, conference presentations, shareholder voting matters, governance updates, and clinical or regulatory disclosures.
The filings also record accounting-practices and internal-control matters, including revenue-recognition disclosures, as well as XBRL financial information covering operating results, equity accounts and reporting-segment data. These documents frame ICON’s public-company reporting around clinical development services, capital structure, governance and risk-related material events.
ICON plc (Nasdaq: ICLR) has submitted a routine Form 6-K dated 18 June 2025 to the U.S. Securities and Exchange Commission. The filing confirms that the company continues to report under Form 20-F requirements for foreign private issuers and is signed by Chief Financial Officer Nigel Clerkin.
The sole attachment, listed as Exhibit 99.1, contains the company’s Unaudited Interim IFRS Single Company Financial Statements. No numerical results, earnings data, or transaction details are provided in the cover document itself. As such, the submission appears to be an administrative update intended to place the interim financial statements on the public record.